A carregar...
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
Clinical trials have demonstrated that an increased number of effector cells, especially tumor-specific T cells, is positively linked with patients’ prognosis. Although the discovery of checkpoint inhibitors (CPIs) has led to encouraging progress in cancer immunotherapy, the lack of either T cells o...
Na minha lista:
| Publicado no: | BMB Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Biochemistry and Molecular Biology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851446/ https://ncbi.nlm.nih.gov/pubmed/33407991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2021.54.1.257 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|